| Literature DB >> 27885760 |
Ling Zhou1,2, Lu-Jia Dong2, Zhi-Yong Gao2, Xin-Jian Yu2, Dao-Pei Lu1,2.
Abstract
CGD is a rare primary immunodeficiency with high mortality rates when treated conventionally, especially for the X-chromosome-linked form. HSCT is the only curative therapy for CGD; however, haploidentical transplantation in CGD is rare. Here, we report a case of X-linked CGD treated successfully by haploidentical HSCT. The patient showed a positive result with full donor chimerism, good quality of life, and the absence of recurrent infectious diseases at follow-up (68 months). Thus, haploidentical HSCT may serve as an acceptable treatment approach for patients who have CGD, but no HLA-matched related or unrelated donor.Entities:
Keywords: X-linked chronic granulomatous disease; haploidentical; myeloablative conditioning
Mesh:
Substances:
Year: 2016 PMID: 27885760 DOI: 10.1111/petr.12861
Source DB: PubMed Journal: Pediatr Transplant ISSN: 1397-3142